Literature DB >> 7790826

Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses.

D J Berg1, M W Leach, R Kühn, K Rajewsky, W Müller, N J Davidson, D Rennick.   

Abstract

We have examined the role of endogenously produced interleukin (IL) 4 and IL-10 in the regulation of inflammatory and immune reactions in the skin. In these experiments, irritant and contact hypersensitivity (CH) responses were elicited in mice with targeted disruptions of the IL-4 (IL-4T) or IL-10 (IL-10T) gene. Our study showed that IL-4T and wild-type (wt) mice exhibited equivalent responses to the irritant croton oil. In contrast, the response of IL-10T mice challenged with croton oil was abnormally increased. When IL-10T mice were exposed to a higher dose of irritant, irreversible tissue damage occurred. By comparison, any treatment of wt mice with croton oil resulted in far less tissue damage and resolution of inflammation. Neutralizing antibody studies demonstrated that the necrosis that occurred in IL-10T mice was due to the overproduction of tumor necrosis factor. The anti-tumor necrosis factor antibody treatment of IL-10T mice did not significantly reduce the edema or the influx of inflammatory cells, suggesting that these changes were due to the uncontrolled production of other proinflammatory cytokines. T cell-dependent immune responses were also evaluated using the contact sensitizer oxazolone. The response of IL-4T mice did not differ from wt mice. In contrast, IL-10T mice mounted an exaggerated CH response, increased in both magnitude and duration as compared with wt mice. Based on these studies, we have concluded that IL-10, but not IL-4, is a natural suppressant of irritant responses and of CH, and it limits immunopathologic damage in the skin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7790826      PMCID: PMC2192105          DOI: 10.1084/jem.182.1.99

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  46 in total

1.  MAST CELL POPULATION IN HUMAN SKIN.

Authors:  G R MIKHAIL; A MILLER-MILINSKA
Journal:  J Invest Dermatol       Date:  1964-10       Impact factor: 8.551

2.  IL-4 down-regulates IL-1 and TNF gene expression in human monocytes.

Authors:  R Essner; K Rhoades; W H McBride; D L Morton; J S Economou
Journal:  J Immunol       Date:  1989-06-01       Impact factor: 5.422

3.  Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2.

Authors:  P H Hart; G F Vitti; D R Burgess; G A Whitty; D S Piccoli; J A Hamilton
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

4.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

Authors:  T R Mosmann; H Cherwinski; M W Bond; M A Giedlin; R L Coffman
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

Review 5.  B-cell stimulatory factor-1/interleukin 4.

Authors:  W E Paul; J Ohara
Journal:  Annu Rev Immunol       Date:  1987       Impact factor: 28.527

6.  Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones.

Authors:  D J Cher; T R Mosmann
Journal:  J Immunol       Date:  1987-06-01       Impact factor: 5.422

7.  Regulatory effect of recombinant interleukin (IL)3 and IL4 on cytokine gene expression of bone marrow and peripheral blood mononuclear cells.

Authors:  S Brantschen; J F Gauchat; A L De Weck; B M Stadler
Journal:  Eur J Immunol       Date:  1989-11       Impact factor: 5.532

8.  Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression.

Authors:  M A Vadas; J F Miller; I F McKenzie; S E Chism; F W Shen; E A Boyse; J R Gamble; A M Whitelaw
Journal:  J Exp Med       Date:  1976-07-01       Impact factor: 14.307

9.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.

Authors:  D F Fiorentino; M W Bond; T R Mosmann
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

10.  Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells.

Authors:  R Peleman; J Wu; C Fargeas; G Delespesse
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

View more
  38 in total

1.  Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.

Authors:  Heike Schäcke; Arndt Schottelius; Wolf-Dietrich Döcke; Peter Strehlke; Stefan Jaroch; Norbert Schmees; Hartmut Rehwinkel; Hartwig Hennekes; Khusru Asadullah
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-23       Impact factor: 11.205

2.  Accelerated wound closure in mice deficient for interleukin-10.

Authors:  Sabine A Eming; Sabine Werner; Philippe Bugnon; Claudia Wickenhauser; Lisa Siewe; Olaf Utermöhlen; Jeffrey M Davidson; Thomas Krieg; Axel Roers
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

3.  The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression.

Authors:  Chun Kim; Yasuyo Sano; Kristina Todorova; Bradley A Carlson; Luis Arpa; Antonio Celada; Toby Lawrence; Kinya Otsu; Janice L Brissette; J Simon C Arthur; Jin Mo Park
Journal:  Nat Immunol       Date:  2008-09       Impact factor: 25.606

4.  IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways.

Authors:  A M O'Farrell; Y Liu; K W Moore; A L Mui
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

5.  Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.

Authors:  D J Berg; N Davidson; R Kühn; W Müller; S Menon; G Holland; L Thompson-Snipes; M W Leach; D Rennick
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

6.  The role of interleukin-4 in ultraviolet B light-induced immunosuppression.

Authors:  A A el-Ghorr; M Norval
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

Review 7.  Cell type-specific regulation of IL-10 expression in inflammation and disease.

Authors:  Christian M Hedrich; Jay H Bream
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

8.  Dietary fatty acids differentially regulate production of TNF-alpha and IL-10 by murine 3T3-L1 adipocytes.

Authors:  Richard L Bradley; F Folliott M Fisher; Eleftheria Maratos-Flier
Journal:  Obesity (Silver Spring)       Date:  2008-02-28       Impact factor: 5.002

9.  Th2 cytokines, IgE and mast cells play a crucial role in the induction of para-phenylenediamine-induced contact hypersensitivity in mice.

Authors:  H Yokozeki; M-H Wu; K Sumi; K Igawa; Y Miyazaki; I Katayama; K Takeda; S Akira; K Nishioka
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

10.  Extravascular inflammation does not increase atherosclerosis in apoE-deficient mice.

Authors:  Kerry W S Ko; David B Corry; Cory F Brayton; Antoni Paul; Lawrence Chan
Journal:  Biochem Biophys Res Commun       Date:  2009-04-22       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.